• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1(PAI-1)在子宫内膜异位症中的表达。

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis.

机构信息

Department of Obstetrics & Gynaecology, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, Canada.

出版信息

PLoS One. 2019 Jul 17;14(7):e0219064. doi: 10.1371/journal.pone.0219064. eCollection 2019.

DOI:10.1371/journal.pone.0219064
PMID:31315131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6637014/
Abstract

PURPOSE

Deep infiltrating endometriosis (DIE) is defined as an endometriotic lesion penetrating to a depth of >5 mm and is associated with pelvic pain, but the underlying mechanisms are unclear. Our objective is to investigate whether plasminogen activator inhibitor-1 expression (PAI-1) in endometriotic tissues is increased in women with DIE.

METHODS

In this blinded in vitro study, immunohistochemistry and Histoscore were used to examine the expression of PAI-1 in glandular epithelium (GECs) and stroma (SCs) in a total of 62 women: deep infiltrating uterosacral/rectovaginal endometriosis (DIE; n = 13), ovarian endometrioma (OMA; n = 14), superficial peritoneal uterosacral/cul-de-sac endometriosis (SUP; n = 23), uterine (eutopic) endometrium from women with endometriosis (UE; n = 6), and non-endometriosis eutopic endometrium (UC; n = 6). The following patient characteristics were also collected: age, American Fertility Society stage, hormonal suppression, phase of menstrual cycle, dysmenorrhea score and deep dyspareunia score.

RESULTS

PAI-1 expression in GECs and SCs of the DIE group was significantly higher than that of SUP group (p = 0.01, p = 0.01, respectively) and UE group (p = 0.03, p = 0.04, respectively). Interestingly, increased PAI-1 expression in GECs and SCs was also significantly correlated with increased dysmenorrhea (r = 0.38, p = 0.01; r = 0.34, p = 0.02, respectively).

CONCLUSIONS

We found higher expression of PAI-1 in DIE, and an association between PAI-1 and worse dysmenorrhea.

摘要

目的

深部浸润型子宫内膜异位症(DIE)定义为子宫内膜异位症病变穿透深度>5 毫米,并与盆腔疼痛相关,但潜在机制尚不清楚。我们的目的是研究 DIE 患者的组织中纤溶酶原激活物抑制剂-1 表达(PAI-1)是否增加。

方法

在这项盲法体外研究中,使用免疫组织化学和 Histoscore 检查了 62 名女性的子宫内膜异位症组织中 PAI-1 在腺体上皮(GECs)和基质(SCs)中的表达:深部浸润型子宫骶骨/直肠阴道子宫内膜异位症(DIE;n=13)、卵巢子宫内膜瘤(OMA;n=14)、浅表腹膜子宫骶骨/子宫陷凹子宫内膜异位症(SUP;n=23)、子宫内膜异位症患者的子宫(在位)子宫内膜(UE;n=6)和非子宫内膜异位症在位子宫内膜(UC;n=6)。还收集了以下患者特征:年龄、美国生育协会分期、激素抑制、月经周期阶段、痛经评分和深部性交痛评分。

结果

DIE 组的 GECs 和 SCs 中 PAI-1 的表达明显高于 SUP 组(p=0.01,p=0.01)和 UE 组(p=0.03,p=0.04)。有趣的是,GECs 和 SCs 中 PAI-1 表达的增加也与痛经的增加显著相关(r=0.38,p=0.01;r=0.34,p=0.02)。

结论

我们发现 DIE 中 PAI-1 的表达较高,且 PAI-1 与更严重的痛经相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/5a5b5de4d5fc/pone.0219064.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/81764c0cd179/pone.0219064.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/ab5ce0301b5b/pone.0219064.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/5a5b5de4d5fc/pone.0219064.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/81764c0cd179/pone.0219064.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/ab5ce0301b5b/pone.0219064.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ba/6637014/5a5b5de4d5fc/pone.0219064.g003.jpg

相似文献

1
Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis.纤溶酶原激活物抑制剂-1(PAI-1)在子宫内膜异位症中的表达。
PLoS One. 2019 Jul 17;14(7):e0219064. doi: 10.1371/journal.pone.0219064. eCollection 2019.
2
Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase-2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis.CD44s、血管内皮生长因子、基质金属蛋白酶-2和Ki-67在腹膜、直肠阴道和卵巢子宫内膜异位症中的表达
J Reprod Med. 2007 Mar;52(3):207-13.
3
Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis.纤溶酶原激活物抑制剂 1 的免疫反应性及其与子宫腺肌病痛经和病灶纤维化的关系。
Reprod Sci. 2021 Aug;28(8):2378-2386. doi: 10.1007/s43032-021-00513-6. Epub 2021 Mar 8.
4
Potential Role of Semaphorin 3A and Its Receptors in Regulating Aberrant Sympathetic Innervation in Peritoneal and Deep Infiltrating Endometriosis.信号素3A及其受体在调节腹膜和深部浸润性子宫内膜异位症中异常交感神经支配方面的潜在作用
PLoS One. 2015 Dec 31;10(12):e0146027. doi: 10.1371/journal.pone.0146027. eCollection 2015.
5
Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis.激素疗法的使用与深部浸润性直肠阴道子宫内膜异位症中神经纤维密度降低有关。
Acta Obstet Gynecol Scand. 2015 Jul;94(7):693-700. doi: 10.1111/aogs.12652. Epub 2015 May 5.
6
Peritoneal endometriosis and "endometriotic" nodules of the rectovaginal septum are two different entities.腹膜子宫内膜异位症和直肠阴道隔的“子宫内膜异位”结节是两种不同的病变。
Fertil Steril. 1996 Sep;66(3):362-8.
7
Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells.从分离培养的子宫内膜异位症、子宫内膜基质和上皮细胞中尿激酶型纤溶酶原激活物、纤溶酶原激活物抑制剂-1和可溶性纤溶酶原激活物受体的基础释放。
Fertil Steril. 2005 Apr;83 Suppl 1:1155-60. doi: 10.1016/j.fertnstert.2004.09.033.
8
Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: a pilot study.深部浸润型直肠阴道子宫内膜异位症患者盆腔前哨淋巴结中雌激素和孕激素受体阳性的子宫内膜异位病变及播散细胞:一项初步研究。
Hum Reprod. 2008 Oct;23(10):2202-9. doi: 10.1093/humrep/den259. Epub 2008 Jul 16.
9
Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis.腹膜和卵巢子宫内膜异位症增殖活性及类固醇受体表达的免疫组织化学分析
Fertil Steril. 1997 Nov;68(5):912-9. doi: 10.1016/s0015-0282(97)00341-5.
10
Role of interleukin-1β in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis.白细胞介素-1β在子宫内膜异位症中神经生长因子表达、神经发生和深部性交痛中的作用。
Hum Reprod. 2020 Apr 28;35(4):901-912. doi: 10.1093/humrep/deaa017.

引用本文的文献

1
Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis.子宫内膜异位症中补体与凝血级联反应的相互作用及Janus激酶抑制剂的潜力——一项网状Meta分析
Front Immunol. 2025 Jul 8;16:1619434. doi: 10.3389/fimmu.2025.1619434. eCollection 2025.
2
Pathophysiology of Endometriosis: Insights from Immunohistochemical Analysis of Ectopic and Eutopic Tissues.子宫内膜异位症的病理生理学:来自异位和在位组织免疫组化分析的见解
Int J Mol Sci. 2025 Jun 22;26(13):5998. doi: 10.3390/ijms26135998.
3
Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2.

本文引用的文献

1
HOXB4 Immunoreactivity in Endometrial Tissues From Women With or Without Endometriosis.患有或未患有子宫内膜异位症的女性子宫内膜组织中的HOXB4免疫反应性
Reprod Sci. 2018 Jun;25(6):950-957. doi: 10.1177/1933719117732164. Epub 2017 Oct 2.
2
Nerve Growth Factor Is Associated With Sexual Pain in Women With Endometriosis.神经生长因子与子宫内膜异位症女性的性交疼痛有关。
Reprod Sci. 2018 Apr;25(4):540-549. doi: 10.1177/1933719117716778. Epub 2017 Jul 4.
3
Multifactorial contributors to the severity of chronic pelvic pain in women.女性慢性盆腔疼痛严重程度的多因素促成因素。
氯伏克托通过直接结合RanBP2来损害胃癌的干性并诱导肿瘤坏死因子介导的坏死性凋亡。
Cell Mol Life Sci. 2025 May 6;82(1):194. doi: 10.1007/s00018-025-05723-8.
4
Nerve Bundle Density and Expression of NGF and IL-1β Are Intra-Individually Heterogenous in Subtypes of Endometriosis.神经束密度和 NGF、IL-1β 的表达在子宫内膜异位症的各亚型中存在个体内异质性。
Biomolecules. 2024 May 15;14(5):583. doi: 10.3390/biom14050583.
5
inhibits gastric cancer progression the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis.丝氨酸蛋白酶抑制剂家族E成员1-细胞外信号调节激酶-1/2轴抑制胃癌进展。
World J Gastrointest Oncol. 2024 May 15;16(5):2123-2140. doi: 10.4251/wjgo.v16.i5.2123.
6
The expression of SERPINE1 in colon cancer and its regulatory network and prognostic value.丝氨酸蛋白酶抑制剂 1 在结肠癌中的表达及其调控网络和预后价值。
BMC Gastroenterol. 2023 Feb 8;23(1):33. doi: 10.1186/s12876-022-02625-y.
7
Huayu Sanjie Enema Liquid Relieves Pain in Endometriosis Model Rats by Inhibiting Inflammation, Peripheral Sensitization, and Pelvic Adhesion.化瘀散结灌肠液通过抑制炎症、外周敏化和盆腔粘连缓解子宫内膜异位症模型大鼠的疼痛。
Evid Based Complement Alternat Med. 2022 Jun 28;2022:5256578. doi: 10.1155/2022/5256578. eCollection 2022.
8
Accelerated Epigenetic Aging Mediates the Association between Vitamin D Levels and Knee Pain in Community-Dwelling Individuals.加速的表观遗传衰老介导了维生素 D 水平与社区居住个体膝关节疼痛之间的关联。
J Nutr Health Aging. 2022;26(4):318-323. doi: 10.1007/s12603-022-1758-z.
9
Blood tests for prediction of deep endometriosis: A case-control study.血液检测用于预测深部子宫内膜异位症:一项病例对照研究。
World J Clin Cases. 2021 Dec 16;9(35):10805-10815. doi: 10.12998/wjcc.v9.i35.10805.
10
Efficacy of niclosamide on the intra-abdominal inflammatory environment in endometriosis.尼氯硝唑对子宫内膜异位症腹腔内炎症环境的疗效。
FASEB J. 2021 May;35(5):e21584. doi: 10.1096/fj.202002541RRR.
Am J Obstet Gynecol. 2016 Dec;215(6):760.e1-760.e14. doi: 10.1016/j.ajog.2016.07.023. Epub 2016 Jul 18.
4
Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor are expressed at tubal ectopic pregnancy implantation sites.促性腺激素释放激素和促性腺激素释放激素受体在输卵管异位妊娠着床部位表达。
Fertil Steril. 2016 Jun;105(6):1620-1627.e3. doi: 10.1016/j.fertnstert.2016.02.003. Epub 2016 Feb 23.
5
Nerve Bundles and Deep Dyspareunia in Endometriosis.子宫内膜异位症中的神经束与深部性交困难
Reprod Sci. 2016 Jul;23(7):892-901. doi: 10.1177/1933719115623644. Epub 2015 Dec 27.
6
Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity.纤溶酶原激活物抑制剂-1的小分子抑制剂具有抗肿瘤和抗血管生成活性。
PLoS One. 2015 Jul 24;10(7):e0133786. doi: 10.1371/journal.pone.0133786. eCollection 2015.
7
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.抑制纤溶酶原激活物抑制剂-1是卵巢癌的一种潜在治疗策略。
Cancer Biol Ther. 2015;16(2):253-60. doi: 10.1080/15384047.2014.1001271.
8
The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.纤溶酶原激活物抑制剂1(PAI-1)水平、PAI-1 4G/5G多态性与心肌梗死之间的关联:一项孟德尔随机化荟萃分析。
Clin Chem Lab Med. 2014 Jul;52(7):937-50. doi: 10.1515/cclm-2013-1124.
9
Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.尿激酶型纤溶酶原激活物抑制剂-1 在尿激酶体内抗肿瘤作用的矛盾现象中的作用。
Mol Cancer Res. 2012 Oct;10(10):1271-81. doi: 10.1158/1541-7786.MCR-12-0145. Epub 2012 Aug 21.
10
A potency of plasminogen activation system in long-term prognosis of endometrial cancer: a pilot study.纤溶酶原激活系统活力与子宫内膜癌长期预后的关系:一项初步研究。
Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):193-9. doi: 10.1016/j.ejogrb.2012.03.031. Epub 2012 Apr 22.